As of 3:10pm ET
| +0.10 / +0.88%|
The 4 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 13.00, with a high estimate of 14.00 and a low estimate of 11.00. The median estimate represents a +13.04% increase from the last price of 11.50.
The current consensus among 4 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.